clofilium has been researched along with Cardiac Hypertrophy in 1 studies
clofilium: RN given refers to parent cpd; structure
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nand, V | 1 |
| Doggrell, SA | 1 |
1 other study available for clofilium and Cardiac Hypertrophy
| Article | Year |
|---|---|
Effects of clofilium on cardiovascular tissues from normo- and hypertensive rats.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiomegaly; Dose-Response Relationship, Drug; | 2000 |